IDXXIdexx Laboratories

1. Aug 4, 2026Laboratories Announces Second Quarter Results.Earnings release · press release
2. May 15, 2026Certificate of Incorporation At the 2026 annual meeting of shareholders of IDEXX Laboratories, Inc. (the “Corporation”) held on May 12, 2026 (the “Annual Meeting”), upon the recommendation of the Corporation’s Board of Directors (the “Board”), the Corporation’s shareholders approved amendments to the Corporation’s …Charter/bylaw amendment or fiscal-year change · Form 8-K
3. May 5, 2026IDEXX Laboratories Announces First.Earnings release · press release
4. Mar 26, 2026On March 24, 2026, IDEXX Laboratories, Inc. (“IDEXX”) and Nimrata Hunt, PhD, Executive Vice President, Global Strategy and Commercial, mutually agreed that Dr. Hunt will cease serving in her current role effective on April 13, 2026 (the “Separation Date”) and will continue to provide advisory services on an as-needed …Director or officer change · Form 8-K
5. Feb 13, 2026On February 13, 2026, Ms. M. Anne Szostak provided IDEXX Laboratories, Inc. (the “Company”) notice of her intention to retire from the Board of Directors (the “Board”) effective immediately following the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”) to be held on May 12, 2026.Director or officer change · Form 8-K
6. Jan 13, 2026On January 11, 2026, Jonathan (Jay) Mazelsky notified IDEXX Laboratories, Inc. (the “Company” or “IDEXX”) of his intent to step down as the Company’s President and Chief Executive Officer effective as of May 12, 2026 (the “Transition Date”) and retire from the Company and the Company’s Board of the Directors (the …Director or officer change · Form 8-K
7. Nov 13, 2025Amendment No. 2 to Fourth Amended and Restated Credit Agreement On November 12, 2025, IDEXX Laboratories, Inc. (the “Company”), with IDEXX Distribution, Inc., IDEXX Operations, Inc., OPTI Medical Systems, Inc., IDEXX Laboratories Canada Corporation, IDEXX B.V., IDEXX Laboratories B.V., IDEXX Laboratories GmbH, and …Material agreement entered · Form 8-K
8. Nov 3, 2025IDEXX Laboratories Announces Third Quarter Results.Earnings release · press release
9. Oct 7, 2025Effective October 6, 2025, the board of directors (the “Board”) of IDEXX Laboratories, Inc. (the “Company”) elected Karen Peacock as an independent Class I Director and appointed her as a member of its Compensation and Talent Committee and Finance Committee.Director or officer change · Form 8-K

Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.